23andMe set to go public via a Virgin Group SPAC merger

Genetics testing and genome research company 23andMe is set to go public via a merger with special purpose acquisition corp (SPAC) VG Acquisition Corp, a vehicle set up by Richard Branson and his company Virgin Group. The transaction is expected to result in 23andMe having around $984 million in cash available at close to spend […]

Read more